Spiroindolone NITD609 is a novel antimalarial drug that targets the P-type ATPase PfATP4.
about
Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and BeyondTetrahydrocarbazoles are a novel class of potent P-type ATPase inhibitors with antifungal activity.Aspergillus fumigatus Copper Export Machinery and Reactive Oxygen Intermediate Defense Counter Host Copper-Mediated Oxidative Antimicrobial Offense.Drug Interactions With the Ca2+-ATPase From Sarco(Endo)Plasmic Reticulum (SERCA).
P2860
Spiroindolone NITD609 is a novel antimalarial drug that targets the P-type ATPase PfATP4.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Spiroindolone NITD609 is a novel antimalarial drug that targets the P-type ATPase PfATP4.
@en
type
label
Spiroindolone NITD609 is a novel antimalarial drug that targets the P-type ATPase PfATP4.
@en
prefLabel
Spiroindolone NITD609 is a novel antimalarial drug that targets the P-type ATPase PfATP4.
@en
P2860
P356
P1476
Spiroindolone NITD609 is a novel antimalarial drug that targets the P-type ATPase PfATP4.
@en
P2093
Helen Turner
P2860
P304
P356
10.4155/FMC.15.177
P577
2016-01-29T00:00:00Z